In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

about

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

Item

http://www.wikidata.org/entity/Q52645932

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@en

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@nl

type

Item

label

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@en

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@nl

prefLabel

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@en

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@nl

P1476

In Vitro Efficacy of Ebselen and BAY 11-7082 Against Naegleria fowleri.

@en

P2093

Andrew T Nelson

http://www.w3.org/2001/XMLSchema#string

Angélica Silva-Olivares

http://www.w3.org/2001/XMLSchema#string

Anjan Debnath

http://www.w3.org/2001/XMLSchema#string

Dionicio Siegel

http://www.w3.org/2001/XMLSchema#string

Mineko Shibayama

http://www.w3.org/2001/XMLSchema#string

P2860

Ebselen: prospective therapy for cerebral ischaemia

Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group

Investigational drug available directly from CDC for the treatment of infections with free-living amebae

In vitro susceptibility of pathogenic Naegleria and Acanthamoeba species to a variety of therapeutic agents.

Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.

Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome

Activation of NF-κB mediates astrocyte swelling and brain edema in traumatic brain injury.

Opportunistic amoebae: challenges in prophylaxis and treatment.

Characterization of brain inflammation during primary amoebic meningoencephalitis.

Successful treatment of primary amebic meningoencephalitis.

P304

414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMICB.2018.00414

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

James H McKerrow

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29559968

http://www.w3.org/2001/XMLSchema#string

P932

5845744

http://www.w3.org/2001/XMLSchema#string